Publications found:
36,694
Sort by:
Global Triamterenes Market Report 2019, Competitive Landscape, Trends and Opportunities
US$ 2,950.00
The Triamterenes market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated ... provides crucial information for knowing the Triamterenes market. Major players in the global Triamterenes market include: Watson Pharma Private Limited GoodRx ...
July 2019
112 pages
Global Tropisetron Market Report 2019, Competitive Landscape, Trends and Opportunities
US$ 2,950.00
The Tropisetron market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is ... competitors) provides crucial information for knowing the Tropisetron market. Major players in the global Tropisetron market include: Company 1 Company 2 Company 3 Company ...
July 2019
119 pages
Global Zinacef Market Report 2019, Competitive Landscape, Trends and Opportunities
US$ 2,950.00
The Zinacef market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is ... industry competitors) provides crucial information for knowing the Zinacef market. Major players in the global Zinacef market include: Company 1 Company 2 Company 3 Company ...
July 2019
112 pages
Animal Health Market Consolidation, 2019-2023: Who will not survive?
US$ 2,450.00
... VPGMarketResearch analyzes strategies, marketing tactics and technological know-how of the world's leading animal health companies, including: Five ... on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing ...
July 2019
110 pages
Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
... . The cancer therapeutics market is segmented based on application, top selling drugs, and region. Based on application, the market is divided into blood cancer, lung cancer, colorectal cancer, prostate cancer, breast cancer, cervical cancer ...
July 2019
261 pages
Narcolepsy Drugs Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others) and Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
... lucrative opportunities for market expansion. The global narcolepsy drugs market is segmented based on disease type, therapeutics type, and geography. Depending on disease type, the market is categorized into ...
July 2019
166 pages
Dupixent- Drug Insight, 2019
US$ 1,000.00
... the Dupixent SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Dupixent Access to Dupixent API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Dupixent patents ...
July 2019
35 pages
Imfinzi- Drug Insight, 2019
US$ 1,000.00
... the Imfinzi SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Imfinzi Access to Imfinzi API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Imfinzi patents ...
July 2019
35 pages
Ocrevus- Drug Insight, 2019
US$ 1,000.00
... the Ocrevus SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Ocrevus Access to Ocrevus API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Ocrevus patents ...
July 2019
35 pages
Parsabiv- Drug Insight, 2019
US$ 1,000.00
... the Parsabiv SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Parsabiv Access to Parsabiv API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Parsabiv patents ...
July 2019
35 pages
Radicava- Drug Insight, 2019
US$ 1,000.00
... the Radicava SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Radicava Access to Radicava API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Radicava patents ...
July 2019
35 pages
Rydapt- Drug Insight, 2019
US$ 1,000.00
... the Rydapt SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Rydapt Access to Rydapt API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Rydapt patents ...
July 2019
35 pages
Symproic- Drug Insight, 2019
US$ 1,000.00
... the Symproic SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Symproic Access to Symproic API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Symproic patents ...
July 2019
35 pages
Parainfluenza Virus Infection Market Insights, Epidemiology and Market Forecast-2028
US$ 7,500.00
... Parainfluenza Virus Infection market. Parainfluenza Virus Infection Report Insights Patient Population Therapeutic Approaches Market Size and Trends Market Opportunities Impact of upcoming Therapies Parainfluenza Virus Infection Report Key Strengths 10 Year Forecast G8 Coverage Epidemiology Segmentation Drugs ...
July 2019
127 pages
Balversa- Drug Insight, 2019
US$ 1,000.00
... the Balversa SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Balversa Access to Balversa API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Balversa patents ...
July 2019
35 pages
Bevyxxa- Drug Insight, 2019
US$ 1,000.00
... the Bevyxxa SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Bevyxxa Access to Bevyxxa API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Bevyxxa patents ...
July 2019
35 pages
Biktarvy- Drug Insight, 2019
US$ 1,000.00
... the Biktarvy SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Biktarvy Access to Biktarvy API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Biktarvy patents ...
July 2019
35 pages
Erleada- Drug Insight, 2019
US$ 1,000.00
... the Erleada SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Erleada Access to Erleada API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Erleada patents ...
July 2019
35 pages
Fasenra- Drug Insight, 2019
US$ 1,000.00
... the Fasenra SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Fasenra Access to Fasenra API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Fasenra patents ...
July 2019
35 pages
Galafold- Drug Insight, 2019
US$ 1,000.00
... the Galafold SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Galafold Access to Galafold API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Galafold patents ...
July 2019
35 pages
Hemlibra- Drug Insight, 2019
US$ 1,000.00
... the Hemlibra SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Hemlibra Access to Hemlibra API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Hemlibra patents ...
July 2019
35 pages
Lutathera- Drug Insight, 2019
US$ 1,000.00
... the Lutathera SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Lutathera Access to Lutathera API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Lutathera patents ...
July 2019
35 pages
